Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087

CODEN : IJPPTK

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs. With more...

Article type

Original Article


Article page

179-186


Authors Details

Bhavani V, Nagabushan H*, Bhagyavathi H. D


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 2969

PDF Downloaded: 1148


Oral flunarizine versus oral amitriptyline in migraine prophylaxis – A prospective open label study


Original Article

Author Details : Bhavani V, Nagabushan H*, Bhagyavathi H. D

Volume : 5, Issue : 4, Year : 2018

Article Page : 179-186

https://doi.org/10.18231/2393-9087.2018.0037



Suggest article by email

Get Permission

Abstract

Objectives: To compare the effectiveness and tolerability of flunarizine and amitriptyline in migraine prophylaxis. Also to assess the disability associated with migraine using Migraine Disability Assessment Test (MIDAS) and Headache Impact Test-6 (HIT-6) questionnaires.
Materials and Methods: The study was a prospective observational, open-label, comparative study, conducted for six months among migraine patients attending Tertiary Care Hospital, Mandya. Patients were prescribed either Amitriptyline 25 mg or flunarizine 10 mg OD for three months. Effectiveness was assessed by the number of episodes of migraine attacks, pain severity score on Visual Analogue Scale (VAS), tolerability of adverse reactions reported and disability assessed using MIDAS and HIT-6 questionnaires.
Results: Out of 103 patients, 55 were prescribed Amitriptyline and 48 patients flunarizine. 49.5% of patients were between 18 to 30 years of age. At the end of three months of treatment, the frequency and severity of headaches decreased from baseline in both the groups. The overall percentage of responders with >50% reduction from baseline in number of migraine episodes and pain severity together were 67.3% and 50% in amitriptyline and flunarizine groups respectively. There was reduction in MIDAS and HIT-6 scores in both groups, without significant difference between the groups. Both the drugs were well tolerated, with most common adverse effects being dry mouth, somnolence, and constipation.
Conclusion: Both amitriptyline and flunarizine are effective in prophylaxis of migraine, with significant reduction in number of episodes and severity of headache from baseline to end of treatment. However, Amitriptyline had a higher overall responder rate when compared to Flunarizine, with similar tolerability profile.

Keywords: Migraine prophylaxis, Amitriptyline, Flunarizine, MIDAS, HIT-6.


How to cite : Bhavani V, Nagabushan H, Bhagyavathi H. D, Oral flunarizine versus oral amitriptyline in migraine prophylaxis – A prospective open label study. Indian J Pharm Pharmacol 2018;5(4):179-186

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.